Hormel Foods Corporation FY2025 revenue ~$11.7-12.0B (-1 to +2%) with adj. EPS ~$1.50-1.60 reflecting continued post-2022-2024 packaged food volume normalization (selected center-store grocery weakness + selected Jennie-O Turkey volatility) + selected Transform & Modernize initiative cost savings + selected operational excellence under continued CEO Jim Snee. Leading US protein + branded food firm operating SPAM + Hormel + Planters + Skippy + Jennie-O Turkey + Justin's + Applegate + selected lifestyle brands; founded 1891 by George A. Hormel in Austin Minnesota originally as Geo. A. Hormel & Co. meatpacker (later expanded to branded protein products; SPAM introduced 1937; IPO 1928); headquartered in Austin Minnesota; ~20,000+ employees across selected ~80+ countries; fiscal year ends ~October. 3 segments: Retail 64% ($7.6B — SPAM canned meat #1 in category since 1937 ~85+ year heritage + Hormel branded ham/bacon + Planters salted snack nuts post-June 2021 $3.35B acquisition from Kraft Heinz + Skippy peanut butter + Jennie-O Turkey retail + Justin's nut butters + Applegate organic protein) + Foodservice 26% ($3.1B — selected QSR + selected institutional K-12 + selected colleges + selected hospitals + selected commercial bacon) + International 10% ($1.1B — China selected SPAM + selected ~$200-300M + selected Mexico). Note: Jennie-O Turkey integrated into Retail + Foodservice segments post-FY2022 reorganization (previously standalone segment). CEO Jim Snee since November 2016 (succeeded Jeff Ettinger CEO 2005-October 2016 retired; Snee ex-Hormel President + COO 2015-2016 + ex-Hormel Foods International President 2010-2014 + ~30+ year Hormel career). Key transactions: 2018 Columbus Manufacturing $850M premium deli meat + June 2021 Planters $3.35B from Kraft Heinz (transformational snack nuts addition; ~$1.2B+ revenue contribution FY2025) + 2023 Transform & Modernize initiative launch ($250M+ annual cost savings target). Selected Hormel Foundation owns ~46% (selected family-aligned governance). Capital return: dividend $1.13-1.16/share annual (~58 consecutive year increases — Dividend King 50+) + buybacks $50-150M (selected modest post-Planters deleveraging focus); investment-grade A1/A credit rating. FY2026 thesis: Planters integration + Transform & Modernize savings + International growth + capital return. Risks: protein volume cyclicality, Jennie-O Turkey volatility (avian flu cyclical), commodity cost (pork + turkey + packaging), GLP-1 long-term, competitive intensity (Tyson + Smithfield).

[HRL] Hormel Foods Thesis 2026: Planters and SPAM Brand Mix Tests Protein Volume Recovery

Key Takeaways

FY2025 revenue ~$11.7-12.0B (-1 to +2% YoY) with adj. EPS ~$1.50-1.60 — Hormel Foods Corporation is the leading US protein + branded food firm operating SPAM + Hormel + Planters (post-2021 $3.35B Kraft Heinz acquisition) + Skippy + Jennie-O Turkey + Justin's + Applegate + selected lifestyle brands. FY2025 reflects continued post-2022-2024 packaged food volume normalization (selected center-store grocery weakness + selected Jennie-O Turkey volatility) + selected Transform & Modernize initiative cost savings + selected operational excellence under continued CEO Jim Snee. Fiscal year ends late October/early November.
Three segments: Retail ~64% + Foodservice ~26% + International ~10% — Retail ~$7.6B FY2025 (SPAM + Hormel + Planters + Skippy + Jennie-O retail + selected; ~10-12% segment operating margin) + Foodservice ~$3.1B (selected QSR + institutional + selected K-12 + selected; ~12-14% segment operating margin) + International ~$1.1B (China + selected Mexico + selected; ~14-16% segment operating margin); selected post-2021 Planters $3.35B acquisition was transformational snack nuts addition.
CEO Jim Snee since November 2016 (~9-year tenure) — Snee succeeded Jeff Ettinger (CEO 2005-October 2016 retired). Snee background: ex-Hormel President + COO 2015-2016 + ex-Hormel Foods International President 2010-2014 + ex-Hormel various roles + ~30+ year Hormel career. Snee's tenure has executed: November 2016 CEO transition + 2017-2020 selected continued operational excellence + 2018 selected acquisitions + June 2021 Planters $3.35B acquisition from Kraft Heinz (transformational snack nuts addition) + 2022-2024 selected post-pandemic packaged food volume normalization + 2023 Transform & Modernize initiative launch ($250M+ annual cost savings target) + selected Jennie-O Turkey supply chain challenges + selected continued discipline. Capital return: dividend $1.13-1.16/share annual (~58 consecutive year increases — Dividend King 50+) + buybacks limited (selected post-Planters deleveraging focus); investment-grade A1/A credit rating.
FY2026 thesis: Planters integration + Transform & Modernize savings + International growth + capital return — Continued post-2021 Planters integration + selected Transform & Modernize initiative cost savings continuation ($250M+ annual target) + selected International (China + selected) growth + selected operational excellence + selected dividend King continuity. Key risks: protein volume cyclicality (selected turkey + selected pork supply/demand), commodity cost (selected pork + selected turkey + selected packaging), Jennie-O Turkey volatility (selected ongoing supply chain + selected disease challenges), GLP-1 weight-loss drug demand impact long-term, competitive intensity (Tyson + Smithfield + Hillshire + selected DTC).

Company Background

Hormel Foods Corporation (NYSE: HRL), founded 1891 by George A. Hormel in Austin Minnesota originally as Geo. A. Hormel & Co. meatpacker (later expanded to branded protein products; SPAM introduced 1937; IPO 1928), is the leading US protein + branded food firm. Headquartered in Austin, Minnesota, Hormel operates ~20,000+ employees across selected ~80+ countries with ~$11.7-12.0B revenue. Hormel's competitive moat rests on three structural advantages: (1) selected branded protein category leadership — SPAM canned meat (selected #1 in category since 1937; ~85+ year heritage) + Hormel branded ham/bacon + Skippy peanut butter + selected provides selected #1-3 US branded protein/center-store positions; (2) selected post-Planters expansion — June 2021 Planters $3.35B acquisition from Kraft Heinz created selected #1 US salted snack nuts brand + selected ~$1.2B+ revenue contribution + selected diversification beyond protein; (3) selected dividend King heritage — ~58 consecutive year dividend increases provides selected income-oriented investor base + selected pricing power discipline; selected Dividend King 50+ status; selected legacy of disciplined operational excellence + selected Hormel family governance (Hormel Foundation owns ~46% selected; selected family-aligned governance).

CEO Jim Snee took CEO role November 2016 (succeeded Jeff Ettinger CEO 2005-October 2016 who retired). Snee's background:

Hormel President + COO (2015-2016)
Hormel Foods International President (2010-2014)
Hormel various roles (1989-2010)
~30+ year Hormel career
Selected operational + brand heritage

Snee's tenure has executed:

November 2016 CEO Transition: succession from Ettinger to Snee
2017-2020 Continued Operational Excellence: continued operational excellence + selected acquisitions
2018 Columbus Manufacturing Acquisition: $850M premium deli meat
2020 COVID Disruption + Recovery: selected operational resilience + selected SPAM demand boom
June 2021 Planters Acquisition: $3.35B from Kraft Heinz; transformational snack nuts addition
2022 Commodity Inflation: selected pricing pass-through
2022-2024 Volume Normalization: selected post-pandemic packaged food volume normalization
2023 Transform & Modernize Initiative: $250M+ annual cost savings target launch
2023-2024 Jennie-O Turkey Volatility: selected supply chain + selected disease challenges
2024 Continued Discipline: continued operational excellence + selected Transform & Modernize execution

Snee's strategic positioning emphasizes:

Planters integration completion + selected snack nuts category growth
Selected Transform & Modernize cost savings continuation
Selected International (China + selected) growth
Selected Jennie-O Turkey stabilization
Selected operational excellence + selected efficiency
Capital return discipline (Dividend King continuity + selected modest buybacks)

Business Structure

Hormel Foods reports operations across 3 segments:

1. Retail — selected ~$7.6B FY2025 (~64% of revenue):

SPAM canned meat
Hormel branded ham/bacon
Planters (acquired 2021)
Skippy peanut butter
Jennie-O Turkey retail
Justin's nut butters + Applegate organic protein + selected
Operating margin variable (~10-12%)

2. Foodservice — selected ~$3.1B FY2025 (~26% of revenue):

Selected QSR + selected institutional (selected K-12 + selected colleges + selected hospitals)
Selected commercial bacon + selected commercial protein
Operating margin variable (~12-14%)

3. International — selected ~$1.1B FY2025 (~10% of revenue):

China (selected SPAM + selected; ~$200-300M)
Selected Mexico + selected
Operating margin variable (~14-16%)

Note: Jennie-O Turkey integrated into Retail + Foodservice segments post-FY2022 reorganization (previously standalone segment).

Key Core Metrics

Financial Performance Summary (Fiscal Year Ends ~October)

Metric	FY2022	FY2023	FY2024	FY2025E
Revenue ($B)	12.5	12.1	11.9	11.7-12.0
Adj. EPS ($)	1.84	1.61	1.58	1.50-1.60
Adj. operating margin (%)	11.5	10.5	10.0	9.5-10.5
Retail revenue ($B)	8.0	7.7	7.6	7.5-7.7
Foodservice ($B)	3.5	3.3	3.2	3.0-3.2
International ($B)	1.0	1.1	1.1	1.1-1.2
Diluted shares (M)	545	545	545	545
Annual dividend/share ($)	1.04	1.10	1.13	1.13-1.16

Capital Return Framework (FY2025)

Component	Annual ($M)	Per Share ($)
Dividend	~620	1.13-1.16
Buybacks	~50-150	(selected modest post-Planters deleveraging)
Total capital return	~670-770

Market Evaluation

Hormel Foods Corporation trades at ~20-22x forward earnings with ~3.5% dividend yield, reflecting consumer staples + Dividend King + Hormel Foundation ownership valuation framework where investors price near-term Planters integration + Transform & Modernize savings + Jennie-O Turkey stabilization + capital return into multiple. Bull case: continued Planters integration + selected Transform & Modernize cost savings continuation ($250M+ annual target) + selected International growth + selected operational excellence + selected Dividend King continuity (~58 years). Bear case: protein volume cyclicality (selected turkey + selected pork supply/demand), commodity cost (selected pork + selected turkey + selected packaging), Jennie-O Turkey volatility (selected ongoing supply chain + selected disease challenges), GLP-1 weight-loss drug demand impact long-term, competitive intensity (Tyson + Smithfield + Hillshire + selected DTC).

Compared to peers: HRL vs Tyson Foods (TSN, much larger ~$53B revenue + diversified protein chicken/beef/pork); HRL vs Smithfield Foods (private/listed Hong Kong; pork focus); HRL vs Pilgrim's Pride (PPC, larger ~$18B revenue + chicken focus); HRL vs Conagra Brands (CAG, similar ~$12B revenue + frozen food + center-store); HRL vs Kraft Heinz (KHC, larger ~$26B revenue + condiments/packaged food); HRL vs Mondelez (MDLZ, larger ~$36B revenue + dominant snacking); HRL vs J.M. Smucker (SJM, smaller ~$8.5B revenue + Jif/Folgers); HRL vs Bumble Bee + selected. Hormel's branded protein category leadership + Planters snack nuts + ~58-year Dividend King + Hormel Foundation governance create structural competitive advantages.

Planters Integration + Transform & Modernize + International + Capital Return

The FY2026 thesis for Hormel Foods centers on Planters integration completion + Transform & Modernize cost savings + International growth + capital return.

Planters Integration:

$3.35B acquisition from Kraft Heinz closed June 2021
Selected #1 US salted snack nuts brand
~$1.2B+ revenue contribution FY2025
Selected snacking category synergies + selected channel expansion
FY2026 expected: continued integration + selected Planters revenue toward $1.25-1.35B (+2-4%)

Transform & Modernize Initiative:

$250M+ annual cost savings target launched 2023
Selected supply chain optimization + selected SG&A discipline + selected manufacturing footprint
Selected ~$80-100M FY2025 incremental savings
FY2026 expected: continued execution toward full $250M+ annual run-rate

International Growth:

International revenue ~$1.1B FY2025 (~10% of total)
China ~$200-300M (selected SPAM + selected)
Selected Mexico + selected
FY2026 expected: International revenue +5-10%

Jennie-O Turkey Stabilization:

Selected post-2022-2024 supply chain + selected disease challenges
Selected post-FY2022 reorganization into Retail + Foodservice segments
Selected commodity turkey volatility
FY2026 expected: continued stabilization + selected modest recovery

Operational Excellence:

Adj. operating margin ~9.5-10.5% FY2025 (vs 11.5% FY2022 peak)
Selected Transform & Modernize savings
Selected SG&A discipline
FY2026 expected: adj. operating margin sustained 10-11%

Capital Return:

Dividend $1.13-1.16/share FY2025 (~58 consecutive year increases — Dividend King 50+)
Dividend yield ~3.5%
Buybacks $50-150M FY2025 (selected modest post-Planters deleveraging focus)
Total capital return $670-770M
Net debt $3-4B (selected post-Planters deleveraging)
Investment-grade A1/A
Selected Hormel Foundation owns ~46% (selected family-aligned governance)

FY2026 Outlook:

Revenue toward $11.8-12.2B FY2026 (+1-3% on volume stabilization + Planters + International)
Adj. EPS toward $1.55-1.70 (+3-10% on operational excellence + selected Transform & Modernize)
Adj. operating margin sustained 10-11%
Capital return $700-850M
Dividend toward $1.16-1.20/share (continued ~58-year King track)
FY2027 outlook: revenue $12-12.5B (+2-3%), adj. EPS $1.65-1.80 (+5-7%), capital return $750-950M

Key Risks:

Protein volume cyclicality (selected turkey + selected pork supply/demand; ~$50-100M annual revenue impact per 5% volume decline)
Commodity cost (selected pork + selected turkey + selected packaging; ~$30-60M annual margin impact per 10% commodity inflation)
Jennie-O Turkey volatility (selected ongoing supply chain + selected disease challenges; selected avian flu cyclical risk)
GLP-1 weight-loss drug demand impact long-term (selected processed protein + selected center-store sweets impacted; ~10-15 year transition; ~$200-400M annual revenue impact long-term per 5% category decline)
Competitive intensity (Tyson + Smithfield + Hillshire + selected DTC + selected plant-based protein)
Selected Planters integration tail risk
Selected Transform & Modernize execution friction
Selected long-tenured Snee succession transition risk (~9-year tenure)

FY2026 Watch Items:

Volume trajectory (target stabilization)
Adj. operating margin (target 10-11%)
Adj. EPS growth (target +3-10%)
Transform & Modernize savings progress
Planters revenue growth (target +2-4%)
International growth (target +5-10%)
Capital return execution (target $700-850M)
Dividend increase (~58-year King track)

Hormel Foods Corporation's FY2026 thesis is Planters integration completion + Transform & Modernize cost savings + International growth + capital return. Validation: Planters delivers + Transform savings continue + Jennie-O stabilizes + Dividend King sustains = thesis intact. Failure mode: protein volume cyclicality severe + commodity cost severe + Jennie-O volatility severe + GLP-1 demand impact accelerating = branded protein franchise Snee cannot fully insulate against despite ~58-year King discipline.